Powder -20℃ 3 years; 4℃ 2 years In solvent -80℃ 6 months; -20℃ 1 month
研究领域:
Inflammation/Immunology Neurological Disease
Target:
CXCR8
描述:
Kynurenic acid sodium, an endogenous tryptophan metabolite, is a broad-spectrum antagonist targeting <b >NMDA, glutamate, α7 nicotinic acetylcholine receptor. Kynurenic acid is also a selective ligand of the GPR35 receptor.